Glow-in-the-Dark dye could help surgeons spot brain tumors
NCT ID NCT07493447
First seen Mar 29, 2026 · Last updated Jun 17, 2026 · Updated 17 times
Summary
This early-stage study tests a fluorescent dye called panitumumab-IRDye800 to see if it is safe and can help surgeons spot brain tumors during surgery. The dye attaches to a protein found on many cancer cells and glows under a special camera. About 30 adults with brain lesions (such as meningioma or glioblastoma) who are already scheduled for surgery will take part. The main goal is to check for side effects and see how well the dye highlights tumor tissue compared to healthy brain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.